$HROW
HARROW, INC. Stock $hrow

$hrow Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223016414 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$33.47M	$26.10M	$22.12M
YoY Change	43.51%	18.01%	43.26%
Cost Of Revenue	$10.00M	$8.271M	$5.963M
YoY Change	53.05%	38.71%	58.17%
Gross Profit	$23.47M	$17.83M	$16.16M
YoY Change	39.79%	10.37%	38.45%
Gross Profit Margin	70.12%	68.31%	73.04%
Selling, General & Admin	$19.96M	$15.89M	$13.40M
YoY Change	40.69%	18.58%	64.19%
% of Gross Profit	85.03%	89.1%	82.92%
Research & Development	$1.161M	$734.0K	$658.0K
YoY Change	27.02%	11.55%	11.53%
% of Gross Profit	4.95%	4.12%	4.07%
Depreciation & Amortization	$228.0K	$225.0K	$823.0K
YoY Change	-72.26%	-72.66%	64.6%
% of Gross Profit	0.97%	1.26%	5.09%
Operating Expenses	$21.12M	$16.62M	$14.06M
YoY Change	39.86%	18.26%	60.46%
Operating Profit	$2.352M	$1.210M	$2.101M
YoY Change	39.17%	-42.41%	-27.8%
Interest Expense	$5.704M	$4.747M	-$4.539M
YoY Change	-172.3%	-204.58%	-2.81%
% of Operating Profit	242.52%	392.31%	-216.04%
Other Income/Expense, Net	-$6.596M	-$8.141M	-$4.539M
YoY Change		79.36%
Pretax Income	-$4.244M	-$6.931M	-$2.438M
YoY Change	-31.54%	184.29%	-1208.18%
Income Tax	-$15.00K	-$288.0K
% Of Pretax Income
Net Earnings	-$4.229M	-$6.643M	-$2.438M
YoY Change	-32.22%	172.48%	-1208.18%
Net Earnings / Revenue	-12.64%	-25.45%	-11.02%
Basic Earnings Per Share	-$0.14	-$0.22	-$0.09
Diluted Earnings Per Share	-$0.14	-$0.22	-$89.54K
COMMON SHARES
Basic Shares Outstanding	30.12M shares	29.97M shares	27.23M shares
Diluted Shares Outstanding	30.46M shares	30.29M shares	27.23M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.67M	$26.88M	$50.59M
YoY Change	-42.53%	-46.87%	58.49%
Cash & Equivalents	$22.75M	$19.25M	$41.95M
Short-Term Investments	$6.917M	$7.631M	$8.642M
Other Short-Term Assets	$427.0K	$118.0K	$1.334M
YoY Change	-63.97%	-91.15%	38.96%
Inventory	$8.555M	$9.093M	$4.396M
Prepaid Expenses
Receivables	$18.26M	$12.11M	$5.995M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$60.30M	$51.69M	$62.32M
YoY Change	-6.81%	-17.06%	53.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.633M	$3.586M	$9.815M
YoY Change	-65.89%	-63.46%	-9.54%
Goodwill	$332.0K	$332.0K
YoY Change
Intangibles	$150.1M	$152.0M
YoY Change
Long-Term Investments			$8.247M
YoY Change			227.26%
Other Assets	$288.0K	$288.0K
YoY Change
Total Long-Term Assets	$163.7M	$165.8M	$35.28M
YoY Change	390.7%	369.99%	126.01%
TOTAL ASSETS
Total Short-Term Assets	$60.30M	$51.69M	$62.32M
Total Long-Term Assets	$163.7M	$165.8M	$35.28M
Total Assets	$224.0M	$217.5M	$97.60M
YoY Change	128.42%	122.86%	73.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.51M	$6.237M	$5.595M
YoY Change	30.7%	11.47%	8.01%
Accrued Expenses	$12.37M	$11.40M	$3.556M
YoY Change	157.72%	220.7%	59.46%
Deferred Revenue	$132.0K	$67.00K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$8.000K
YoY Change			-99.7%
Total Short-Term Liabilities	$23.01M	$17.71M	$9.182M
YoY Change	78.08%	92.86%	-8.82%
LONG-TERM LIABILITIES
Long-Term Debt	$169.7M	$168.9M	$71.85M
YoY Change	135.57%	134.99%	552.62%
Other Long-Term Liabilities	$9.214M	$9.412M	$6.823M
YoY Change	19.6%	37.95%	-6.53%
Total Long-Term Liabilities	$178.9M	$178.3M	$78.68M
YoY Change	124.37%	126.57%	329.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.01M	$17.71M	$9.182M
Total Long-Term Liabilities	$178.9M	$178.3M	$78.68M
Total Liabilities	$201.9M	$196.0M	$87.50M
YoY Change	118.75%	123.96%	212.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$120.4M	-$116.1M
YoY Change
Common Stock	$30.00K	$30.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.41M	$21.88M	$10.09M
YoY Change
Total Liabilities & Shareholders Equity	$224.0M	$217.5M	$97.60M
YoY Change	128.42%	122.86%	73.5%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$4.229M	-$6.643M	-$2.438M
YoY Change	-32.22%	172.48%	-1208.18%
Depreciation, Depletion And Amortization	$228.0K	$225.0K	$823.0K
YoY Change	-72.26%	-72.66%	64.6%
Cash From Operating Activities	$4.566M	-$8.214M	$967.0K
YoY Change	-6.05%	-949.43%	-69.88%
INVESTING ACTIVITIES
Capital Expenditures	$250.0K	$496.0K	-$404.0K
YoY Change	-196.15%	-222.77%	92.38%
Acquisitions
YoY Change
Other Investing Activities	-$999.0K	-$130.5M	-$6.000K
YoY Change	-100000.0%	2174466.67%	-40.0%
Cash From Investing Activities	-$1.249M	-$131.0M	-$410.0K
YoY Change	382.24%	31843.9%	86.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	189.0K	$62.16M	-776.0K
YoY Change	-270.27%	-8110.57%	-0.51%
NET CHANGE
Cash From Operating Activities	4.566M	-$8.214M	967.0K
Cash From Investing Activities	-1.249M	-$131.0M	-410.0K
Cash From Financing Activities	189.0K	$62.16M	-776.0K
Net Change In Cash	3.506M	-$77.02M	-219.0K
YoY Change	-21.92%	35069.86%	-109.91%
FREE CASH FLOW
Cash From Operating Activities	$4.566M	-$8.214M	$967.0K
Capital Expenditures	$250.0K	$496.0K	-$404.0K
Free Cash Flow	$4.316M	-$8.710M	$1.371M
YoY Change	-15.7%	-735.3%	-59.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001360214
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	HROW	Equity In Losses Of Unconsolidated Entity EquityInLossesOfUnconsolidatedEntity		usd
CY2022Q1	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax		usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q1	HROW	Equity In Losses Of Unconsolidated Entities EquityInLossesOfUnconsolidatedEntities		usd
CY2022Q1	HROW	Losses On Extinguishment Of Debt LossesOnExtinguishmentOfDebt		usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022Q1	HROW	Purchase Of Product Ndas And Patents PurchaseOfProductNdasAndPatents		usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2022Q1	HROW	Proceeds From Notes Payable1 ProceedsFromNotesPayable1		usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt		usd
CY2022Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt		usd
CY2022Q1	HROW	Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022Q1	HROW	Accrual Of Exit Fee Related To Senior Secured Note AccrualOfExitFeeRelatedToSeniorSecuredNote		usd
CY2022Q1	HROW	Senior Secured Note Financing Fee SeniorSecuredNoteFinancingFee		usd
CY2022Q1	HROW	Income Taxes Owed For Exercise Of Options IncomeTaxesOwedForExerciseOfOptions		usd
CY2023Q1	HROW	Finite Lived Intangible Assets Impairment FiniteLivedIntangibleAssetsImpairment		usd
CY2022Q4	HROW	Accrued Exit Fee For Note Payable Current And Non Current AccruedExitFeeForNotePayableCurrentAndNonCurrent		usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-35814
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Harrow Health, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-0567010
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	102 Woodmont Blvd.
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 610
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37205
CY2023Q1	dei	City Area Code CityAreaCode	(615)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	733-4730
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30121997	shares
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19248000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	96270000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	7631000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	5589000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12111000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6249000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	9093000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6541000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3604000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3611000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	51687000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	118260000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3586000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3486000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2277000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2112000	usd
CY2022Q4	HROW	Deferred Financing Costs DeferredFinancingCosts	1950000	usd
CY2023Q1	HROW	Deferred Tax Asset DeferredTaxAsset	288000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7336000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7513000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	151992000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23725000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	332000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	332000	usd
CY2023Q1	us-gaap	Assets Assets	217498000	usd
CY2022Q4	us-gaap	Assets Assets	157378000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	13794000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	13771000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3103000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4025000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	67000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	113000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	744000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	723000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	17708000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18632000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7137000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7332000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	2275000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	168850000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	104174000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	195970000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	130138000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30056370	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30056370	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29901530	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29901530	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	30000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	30000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	137989000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	137058000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116136000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109493000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	21883000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27595000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-355000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-355000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21528000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27240000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	217498000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	157378000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26103000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22120000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8271000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5963000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	17832000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	16157000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15888000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13398000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	734000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	658000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	16622000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	14056000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1210000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2101000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	4747000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	1792000	usd
CY2022Q1	HROW	Equity In Losses Of Unconsolidated Entity EquityInLossesOfUnconsolidatedEntity	2886000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	2042000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	139000	usd
CY2023Q1	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-5465000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8141000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4539000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6931000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2438000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-288000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6643000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2438000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30289730	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27226819	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10931000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-777000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2016000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2438000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9736000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27240000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	148000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-850000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1633000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6643000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21528000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6643000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2438000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	292000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	419000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2207000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	404000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	177000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	124000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	20000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	761000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	193000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	2042000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	139000	usd
CY2022Q1	HROW	Equity In Losses Of Unconsolidated Entities EquityInLossesOfUnconsolidatedEntities	2886000	usd
CY2023Q1	HROW	Losses On Extinguishment Of Debt LossesOnExtinguishmentOfDebt	5465000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1633000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2016000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-288000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5882000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1535000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2552000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	179000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	29000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-212000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	369000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1111000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1141000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-46000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	7000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8214000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	967000	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6000	usd
CY2023Q1	HROW	Purchase Of Product Ndas And Patents PurchaseOfProductNdasAndPatents	130474000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	496000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	404000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-130970000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-410000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3000	usd
CY2023Q1	HROW	Proceeds From Notes Payable1 ProceedsFromNotesPayable1	4961000	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	61585000	usd
CY2023Q1	HROW	Payment Of Taxes For Vesting Of Restricted Stock Unit PaymentOfTaxesForVestingOfRestrictedStockUnit	661000	usd
CY2022Q1	HROW	Payment Of Taxes For Vesting Of Restricted Stock Unit PaymentOfTaxesForVestingOfRestrictedStockUnit	777000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	148000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	55879000	usd
CY2023Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	59750000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62162000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-776000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-77022000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-219000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	96270000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	42167000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19248000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41948000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	3371000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1617000	usd
CY2023Q1	HROW	Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses	61000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1036000	usd
CY2023Q1	HROW	Accrual Of Exit Fee Related To Senior Secured Note AccrualOfExitFeeRelatedToSeniorSecuredNote	2275000	usd
CY2023Q1	HROW	Senior Secured Note Financing Fee SeniorSecuredNoteFinancingFee	1950000	usd
CY2023Q1	HROW	Income Taxes Owed For Exercise Of Options IncomeTaxesOwedForExerciseOfOptions	189000	usd
CY2023Q1	HROW	Consolidation Basis Description ConsolidationBasisDescription	entities in which it holds and/or controls, directly or indirectly, more than 50% of the voting rights
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	12111000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	82000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	73000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	20000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	11000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	82000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	36000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	38000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6643000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2438000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30289730	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27226819	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0416	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4034000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2796000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	9093000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6541000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	6449000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26103000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22120000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	67000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	113000	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4335000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4259000	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	6555000	usd
CY2023Q1	HROW	Rreimbursable Expenses RreimbursableExpenses	908000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5023000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3707000	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	527000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	858000	usd
CY2023Q1	us-gaap	Prepaid Royalties PrepaidRoyalties	1072000	usd
CY2022Q4	us-gaap	Prepaid Royalties PrepaidRoyalties	1165000	usd
CY2023Q1	us-gaap	Other Receivables OtherReceivables	198000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	139000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1689000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1331000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	118000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	118000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3604000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3611000	usd
CY2023Q1	HROW	Computer Hardware Gross ComputerHardwareGross	1060000	usd
CY2022Q4	HROW	Computer Hardware Gross ComputerHardwareGross	979000	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	922000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	860000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12872000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12547000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9286000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9061000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3586000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3486000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	225000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	376000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1574000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1572000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	860000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	793000	usd
CY2023Q1	HROW	Capitalized Computer Software Internal Use In Process CapitalizedComputerSoftwareInternalUseInProcess	1563000	usd
CY2022Q4	HROW	Capitalized Computer Software Internal Use In Process CapitalizedComputerSoftwareInternalUseInProcess	1333000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2277000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2112000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	156270000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-4278000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	151992000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2207000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	404000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	744000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	8777000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	11673000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	11652000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	11652000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	11652000	usd
CY2023Q1	HROW	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	96319000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	151725000	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	6237000	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	6440000	usd
CY2023Q1	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	237000	usd
CY2022Q4	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	575000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	5000000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	5000000	usd
CY2023Q1	HROW	Accrued Transitional Fees Current And Noncurrent AccruedTransitionalFeesCurrentAndNoncurrent	307000	usd
CY2022Q4	HROW	Accrued Transitional Fees Current And Noncurrent AccruedTransitionalFeesCurrentAndNoncurrent	453000	usd
CY2023Q1	HROW	Accrued Ligitation Settlements Current And Noncurrent AccruedLigitationSettlementsCurrentAndNoncurrent	49000	usd
CY2022Q4	HROW	Accrued Ligitation Settlements Current And Noncurrent AccruedLigitationSettlementsCurrentAndNoncurrent	49000	usd
CY2023Q1	HROW	Accrued Exit Fee For Note Payable Current And Non Current AccruedExitFeeForNotePayableCurrentAndNonCurrent	2275000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1964000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1254000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	16069000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	13771000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	13794000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	13771000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	2275000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	14145000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	18695000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	18695000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	147325000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	45030000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	243890000	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	63640000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	180250000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-11400000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	168850000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0661	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y8M19D
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	306000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	166000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	309000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	238000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	925000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1262000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1093000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1114000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	972000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	5829000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11195000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3314000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	7881000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7137000	usd
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	1.47
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	18.35
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2891026	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y3M18D
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	6.03
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2589182	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	5.73
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1633000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2016000	usd
CY2023Q1	HROW	Purchase Of Intangible Asset Included In Accounts Payable And Accrued Expenses PurchaseOfIntangibleAssetIncludedInAccountsPayableAndAccruedExpenses	5000000	usd
CY2022	HROW	Purchase Of Intangible Asset Included In Accounts Payable And Accrued Expenses PurchaseOfIntangibleAssetIncludedInAccountsPayableAndAccruedExpenses	5000000	usd

Files In Submission

Name	View Source	Status
hrow-20230331_pre.xml	Edgar Link	unprocessable
hrow-20230331_cal.xml	Edgar Link	unprocessable
0001493152-23-016414-index-headers.html	Edgar Link	pending
0001493152-23-016414-index.html	Edgar Link	pending
0001493152-23-016414.txt	Edgar Link	pending
0001493152-23-016414-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
hrow-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hrow-20230331_def.xml	Edgar Link	unprocessable
hrow-20230331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HROW
HARROW, INC. Stock $hrow

2023 Q2 Form 10-Q Financial Statement

#000149315223016414 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HROW HARROW, INC. Stock $hrow

2023 Q2 Form 10-Q Financial Statement

#000149315223016414 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HROW
HARROW, INC. Stock $hrow